The vital medicine, made by AstraZeneca, will not be available from November, possibly leaving thousands of women without treatment
Get our breaking news email, free app or daily news podcast
Thousands of women could be left without vital breast cancer and endometriosis medicine when AstraZeneca removes its treatment from the Pharmaceutical Benefits Scheme (PBS) and the private market, experts warn.
Zoladex will no longer be available in Australia from November, as the ABC first reported, but some existing patients will still be able to access it for an additional six months.
Continue reading...
TH
Source
This article was originally published by The Guardian and written by Krishani Dhanji.
Read original article on The Guardian